Precision BioSciences Inc (DTIL)
10.52
-0.32
(-2.95%)
USD |
NASDAQ |
May 03, 16:00
10.38
-0.14
(-1.38%)
After-Hours: 20:00
Precision BioSciences Shareholders Equity (Quarterly): 18.86M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.86M |
| September 30, 2023 | 29.06M |
| June 30, 2023 | 34.04M |
| March 31, 2023 | 40.18M |
| December 31, 2022 | 60.43M |
| September 30, 2022 | 84.38M |
| June 30, 2022 | 103.02M |
| March 31, 2022 | 69.66M |
| December 31, 2021 | 91.17M |
| September 30, 2021 | 101.44M |
| June 30, 2021 | 100.55M |
| Date | Value |
|---|---|
| March 31, 2021 | 58.82M |
| December 31, 2020 | 44.42M |
| September 30, 2020 | 63.82M |
| June 30, 2020 | 85.60M |
| March 31, 2020 | 115.03M |
| December 31, 2019 | 138.31M |
| September 30, 2019 | 155.79M |
| June 30, 2019 | 173.98M |
| March 31, 2019 | 10.83M |
| December 31, 2018 | 39.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
18.86M
Minimum
Dec 2023
173.98M
Maximum
Jun 2019
82.56M
Average
84.38M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Altimmune Inc | 194.10M |
| BioVie Inc | 7.491M |
| Adial Pharmaceuticals Inc | 4.084M |
| Gritstone Bio Inc | 51.85M |
| Humacyte Inc | 13.55M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.78M |
| Total Liabilities (Quarterly) | 140.92M |
| Debt to Equity Ratio | 1.188 |
| Current Ratio | 2.728 |
| Net Debt Paydown Yield | -0.10% |